CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

"Chris has made broad contributions as a member of the CytomX executive team and is a proven crossfunctional leader within the organization," said Sean McCarthy, D.Phil., chief executive officer and chairman of CytomX. "We are excited to announce this promotion, which is a reflection of Chris' financial acumen, strategic leadership and deep commitment to CytomX's mission." About CytomX Therapeutics This press release includes forward-looking statements. Such forward-looking statements involve known and unkn ...